Home › Funds › Bain Capital Life Sciences Investors, LLC › KLRA

Bain Capital Life Sciences Investors, LLC position in KLRA

KAILERA THERAPEUTICS INC · Health Care

Bain Capital Life Sciences Investors, LLC reported holding 22,583,268 shares of KLRA (KAILERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$257.9M, representing 17.75% of its reported portfolio and ranking #1 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed KLRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)22.58M sh
Reported value held$257.90M
Portfolio Weight17.75%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Bain Capital Life Sciences Investors, LLC's KLRA position evolved

Bain Capital Life Sciences Investors, LLC first disclosed a stake in KLRA in Q2 2026 at 22,583,268 shares (US$497.5M). Across 2 filings, Bain Capital Life Sciences Investors, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 22,583,268 shares valued at US$257.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 22.58M $497.51M New
Q3 2026 22.58M $257.90M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KLRA and 13F data

KLRA (KAILERA THERAPEUTICS INC) is a Health Care company. 134 other funds we track also report a position in KLRA — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$299.8M), RTW INVESTMENTS, LP (US$123.1M), Atlas Venture Life Science Advisors, LLC (US$59.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KLRA

All KLRA fund holders →

FAQ

How long has Bain Capital Life Sciences Investors, LLC held KLRA?

Bain Capital Life Sciences Investors, LLC has disclosed KLRA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Bain Capital Life Sciences Investors, LLC's current position in KLRA?

As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 22.58M shares of KLRA (KAILERA THERAPEUTICS INC), valued at $257.90M, representing 17.75% of its reported portfolio and ranking #1.

Has Bain Capital Life Sciences Investors, LLC been buying or selling KLRA?

In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in KLRA.

Which other funds hold KLRA?

Other major institutional holders of KLRA include BAIN CAPITAL INVESTORS LLC, RTW INVESTMENTS, LP, Atlas Venture Life Science Advisors, LLC, among 134 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.